Impairment of the renal p-aminohippurate transport induced by 6-hydroxydopamine

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 5, 2003, Pages 669-674

  Cojocel, C ^a   Thomson, M S ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; CISPLATIN; OXIDOPAMINE; OXYGEN;

AMINO ACID ANALYSIS; AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; IN VITRO STUDY; KIDNEY; KIDNEY CORTEX SLICE; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MALE; NONHUMAN; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY CORTEX; MALE; OXIDOPAMINE; P-AMINOHIPPURIC ACID; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0038381412     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235703765344586     Document Type: Article

References (36)

1. Andrew, R., Watson, D. G., Best, S. A., Midgley, J. M., Wenlong, H., Petty, R. K. (1993) The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem. Res. 18: 1175-1177
2. Apodaca, G., Enrich, C., Mostov, K. E. (1994) The calmodulin antagonist, W-13, alters transcytosis, recycling, and the morphology of the endocytic pathway in Madin-Darby canine kidney cells. J. Biol. Chem. 269: 1905-1913
3. Appenroth, D., Braunlich, H. (1981) Effect of sympathectomy with 6-hydroxydopamine on the renal excretion of water and electrolytes in developing rats. Acta Biol. Med. Ger. 40: 1715-1721
4. Borisenko, G. G., Kangan, V. E., Hsia, C. J., Schor, N. F. (2000) Interaction between 6-hydroxy-dopamine and transferrin: "Let my iron go". Biochemistry 39: 3392-3400
5. Canonne-Hergaux, F., Gruenheid, S., Ponka, P., Gros, P. (1999) Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood 93: 4406-4417
6. Cojocel, C. (1990) Biochemical aspects of the renal tolerance for cefpirome and other cephalosporins. Arzneimittelforschung 40: 1140-1144
7. Cojocel, C., Lock, E. A. (1999) The kidney. In: Marquardt, H. H., Schaefer, S. G., McClellan, R., Welsch, F. (eds) Toxicology. Academic Press, San Diego, London, pp 297-330
8. Cross, R. J., Tagart, J. V. (1950) Renal tubular transport: Accumulation of p-aminohippurate by rabbit kidney slices. Am. J. Physiol. 161: 181-190
9. Ferger, B., Rose, S., Jenner, A., Halliwell, B., Jenner, P. (2001) 6-Hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum. Neuroreport 12: 1155-1159
10. Hirsch, E. C. (1993) Does oxidative stress participate in nerve cell death in Parkinson's disease? Eur. Neurol. 33 (Suppl. 1): 52-59
11. Ho, A. K., McLaughlin, R., Chan, A., Duffield, R. (1999) 6-Hydroxydopamine induced cardiac malformations and alterations of the autonomic nervous system in the developing chicken embryo. Jap. J. Pharmacol. 81: 38-47
12. Jameson, G. N. L., Linert, W. (2000) 6-Hydroxydopamine, dopamine, and ferritin: A cycle of reactions sustaining Parkinson's disease? In: Poli, G., Cadenas, E., Packer, L. (eds) Free Radicals in Brain-Pathophysiology. Marcel-Decker, New York, pp 247-272
13. Jenner, P., Olanow, C. W. (1996) Oxidative stress and the pathogenesis of Parkinson's disease. Am. Neurol. 47 (Suppl. 3): S161-S170
14. Jenner, W. N., Rose, F. A. (1974) Dopamine 3-O-sulphate, an end product of L-dopa metabolism in Parkinson disease. Nature 252: 237-238
15. Kinzel, E., Jellinger, K., Stachelberger, H., Linert, W. (1999) Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease? Life Sci. 65: 1973-1976
16. Linert, W., Jameson, G. N. L. (2000) Redox reactions of neurotransmitter possibly involved in the progression of Parkinson's disease. J. Inorg. Biochem. 79: 319-326
17. Masereeuw, R., Russel, F. G. M., Miller, D. S. (1996) Multiple pathways for organic anion excretion in renal proximal tubule revealed by confocal microscopy. Am. J. Physiol. 271: F1173-F1182
18. Mayo, J. C., Sainz, R., Uria, H., Antolin, I., Esteban, M. M., Rodriguez, C. (1998) Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: Implications for Parkinson's disease. J. Pineal Res. 24: 179-192
19. Miyasaki, J. M., Martin, W., Suchowersky, O., Weiner, W. J., Lang, A. E. (2002) Practice parameter: Initiation of treatment for Parkinson's disease: An evidence-based review: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 58: 11-17
20. Nankivell, B. J., Chen, J., Boadle, R. A., Harris, D. C. (1994) The role of tubular iron accumulation in the remnant kidney. J. Am. Soc. Nephrol. 4: 1598-1607
21. Ochu, E. E., Rothwell, N. J., Waters, C. M. (1998) Caspases mediate 6-hydroxydopamine-induced apoptosis but not necrosis in PC12 cells. J. Neurochem. 70: 2637-2640
22. Oldfield, F. F., Cowan, D. L., Sun, A. Y. (1991) The involvement of ethanol in the free radical reaction of 6-hydroxydopamine. Neurochem. Res. 16: 83-87
23. Plumbo, A., Napolitano, A., Barone, P., D'Ischia, M. (1999) Nitrite- and peroxide-dependent oxidation pathways of dopamine: 6-Nitrodopamine and 6-hydroxydopamine formation as potential contributory mechanisms of oxidative stress- and nitric oxide-induced neurotoxicity in neuronal degeneration. Chem. Res. Toxicol. 12: 1213-1222
24. Reiter, R. J. (1998) Oxidative damage in the central nervous system: Protection by melatonin. Prog. Neurobiol. 56: 359-384
25. Richardson, D. R., Ponka, P. (1997) The molecular mechanism of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta 1331: 1-40
26. Sato, T., Minami, S., Okabe, T., Igarashi, N. (1987) Role of renal cathecholamines in the control of sodium and water excretion: Lack of natriuresis by endogenous dopamine in the rat kidney. Acta Endocrinol. (Copenh.) 116: 326-332
27. Sekine, T., Watanabe, N., Hosoyamada, M., Kanai, Y., Endou, H. (1997) Expression cloning and characterization of novel multispecific organic anion transporter. J. Biol. Chem. 272: 18526-18529
28. Senoh, S., Creveling, C. R., Udenfriend, S., Witkop, B. (1959) Chemical, enzymatic and metabolic studies on the oxidation of dopamine. J. Am. Chem. Soc. 81: 6236-6340
29. Smith, H. W., Finkelstein, N., Aliminosa, L., Crawford, B., Graber, M. (1945) The renal clearance of substituted hippuric acid derivatives and other aromatic acids in dog and man. J. Clin. Invest. 25: 388-404
30. Soto-Otero, R., Mendez-Alvarez, E., Hermida-Ameijeiras, A., Munoz-Patino, A. M., Labandeira-Garcia, J. L. (2000) Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: Potential implication in relation to the pathogenesis of Parkinson's disease. J. Neurochem. 74: 1605-1612
31. Thomas, G. D., Zambrawski, E. J. (1991) Acute renal function in chronically sympathectomized deoxycorticosterone acetate-treated miniature swine. Proc. Soc. Exp. Biol. Med. 197: 331-336
32. Ullrich, K. J. (1997) Renal transporters for organic anions and cations. Structural requirements for substrates. J. Membr. Biol. 158: 95-107
33. Valentovic, M., Meadows, M. K., Harmon, R. C., Ball, J. G., Hong, S. K., Rankin, G. O. (1992) 2-Amino-chlorophenol toxicity in renal cortical slices from Fischer 344 rats: Effect of antioxidants and sulfhydryl agents. Toxicol. Appl. Pharmacol. 161: 1-9
34. Walther, M., Romen, W. (1981) Renal lesions after treatment with 6-hydroxydopamine. Acta Anatomica 111: 159
35. Woodgate, A., MacGibbon, G., Walton, M., Dragunow, M. (1999) The toxicity of 6-hydroxydopamine in PC12 and P19 cells. Brain Res. Mol. Brain Res. 69: 84-92
36. Yousif, T., Pooyeh, S., Hannemann, J., Baumann, J., Tauber, R., Baumann, K. (1999) Nephrotoxic and peroxidative potential of meropenem and imipenem/cilastatin in rat and human renal cortical slices and microsomes. Int. J. Clin. Pharmacol. Ther. 37: 475-486